|
SMARCE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.18780000002427E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.004840E-04 |
| Normal-vs-Stage2 |
4.338000E-02 |
| Normal-vs-Stage3 |
7.083600E-03 |
| Normal-vs-Stage4 |
1.012430E-01 |
| Stage1-vs-Stage2 |
8.491800E-01 |
| Stage1-vs-Stage3 |
5.803400E-01 |
| Stage1-vs-Stage4 |
3.673600E-01 |
| Stage2-vs-Stage3 |
5.661800E-01 |
| Stage2-vs-Stage4 |
3.460400E-01 |
| Stage3-vs-Stage4 |
4.942800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.15240000003936E-06 |
| Normal-vs-AfricanAmerican |
9.190500E-04 |
| Normal-vs-Asian |
1.278150E-01 |
| Caucasian-vs-AfricanAmerican |
6.060600E-01 |
| Caucasian-vs-Asian |
8.457000E-01 |
| AfricanAmerican-vs-Asian |
6.664600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.785800E-04 |
| Normal-vs-Female |
3.44689999876024E-08 |
| Male-vs-Female |
8.247700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.620030E-02 |
| Normal-vs-Extreme_Weight |
3.124900E-03 |
| Normal-vs-Obese |
3.86350000000091E-05 |
| Normal-vs-Extreme_Obese |
8.245900E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.270400E-01 |
| Normal_Weight-vs-Obese |
7.173200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.034400E-01 |
| Extreme_Weight-vs-Obese |
2.357000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.889800E-01 |
| Obese-vs-Extreme_Obese |
3.432200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.97839999999517E-05 |
| Normal-vs-Age(41-60Yrs) |
2.27590000179134E-08 |
| Normal-vs-Age(61-80Yrs) |
1.288130E-02 |
| Normal-vs-Age(81-100Yrs) |
9.333800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.105600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.01769999999391E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.803400E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.357500E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.440420E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.478400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.22590000040113E-07 |
| Normal-VS-Type2 PRCC |
2.301000E-01 |
| Normal-VS-KIRP CIMP |
1.521680E-03 |
| Normal-VS-Unclassified PRCC |
5.341900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.216500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.282200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.065000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.078800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.445800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.950200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.614250E-01 |
| Normal-vs-N1 |
1.056800E-03 |
| Normal-vs-N2 |
2.800000E-02 |
| N0-vs-N1 |
4.656600E-03 |
| N0-vs-N2 |
2.835000E-01 |
| N1-vs-N2 |
4.527200E-01 |
|
|
